Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Beta Drugs Ltd.
Swot
Beta Drugs Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Beta Drugs Ltd. has 10 Strengths, 7 Weaknesses, 0 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(10)
Weakness
(7)
Opportunity
(0)
Threats
(0)
Others
(1)
Consistent Highest Return Stocks over Five Years - Nifty500
Rising Net Cash Flow and Cash from Operating activity
Relative Outperformance versus Industry over 1 Year
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Company with Low Debt
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Company with Zero Promoter Pledge
Top Gainers
PE higher than Industry PE
High PE (PE > 40)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of capital to generate profits - RoCE declining in the last 2 years
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Stocks Underperforming their Industry Price Change in the Quarter
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
